Goldman Sachs rates Vaxcyte a buy with $135 price target, highlighting vaccine platform and pneumonia candidate. Read more ...

As we are approaching winter and there is an increase in respiratory diseases, it’s also important to know about pneumococcal ...

The following is a summary of “Evaluating Sex Differences in Pneumococcal Disease Burden and Vaccination Effectiveness in ...

Pneumonia is a lung infection that annually impacts millions of people around the globe, according to the Centers for Disease ...

Pneumonia can be caused by a virus, bacteria or fungus. Each of these can cause an immune reaction in the tissues of the ...

The Centers for Disease Control and Prevention (CDC) has issued an update to the recommendations for universal hepatitis B vaccination in adults aged 19 to 59 years. The study included 75 pregnant ...

Finally, we hypothesized that such an antigen-specific response can be manipulated to preventively reduce the severity of PO-HF in a tolerizing vaccine. We found that PO-HF fulfills the criteria of an ...

Nova Scotia's chief medical officer of health says that as misinformation has fuelled doubt about the safety and efficacy of vaccines, the benefits of vaccination are being forgotten. Dr. Robert ...

This vaccine offers broader protection than existing vaccines by covering 14 pneumococcal strains, addressing infections like pneumonia and meningitis. Abbott India on Wednesday announced the launch ...

After pneumococcal disease and colonization have been controlled through vaccination, a PCV schedule with a single primary dose and booster dose (1p+1) may be sufficient to sustain that control at ...